AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 116 filers reported holding AXSOME THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $726,000 | +44.6% | 10,760 | +74.6% | 0.00% | – |
Q4 2020 | $502,000 | -36.0% | 6,162 | -44.0% | 0.00% | -100.0% |
Q3 2020 | $784,000 | -73.8% | 10,999 | -78.3% | 0.00% | -75.0% |
Q1 2020 | $2,989,000 | -5.4% | 50,794 | +66.3% | 0.00% | +33.3% |
Q4 2019 | $3,158,000 | +400.5% | 30,550 | -2.1% | 0.00% | +200.0% |
Q3 2019 | $631,000 | -63.6% | 31,191 | -53.7% | 0.00% | -50.0% |
Q2 2019 | $1,735,000 | +146.4% | 67,373 | -46.4% | 0.00% | +100.0% |
Q4 2017 | $704,000 | +1.0% | 125,670 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $697,000 | -3.6% | 125,670 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $723,000 | +44.6% | 125,670 | -2.0% | 0.00% | – |
Q1 2017 | $500,000 | -32.7% | 128,200 | +16.5% | 0.00% | -100.0% |
Q4 2016 | $743,000 | -12.3% | 110,090 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $847,000 | -5.8% | 110,090 | -7.7% | 0.00% | 0.0% |
Q2 2016 | $899,000 | -12.3% | 119,240 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $1,025,000 | -4.9% | 119,240 | +1.8% | 0.00% | 0.0% |
Q4 2015 | $1,078,000 | – | 117,165 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |